ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,0874
-0,15%
Bitcoin
66.794,77
-0,22%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Immune Therapeutics Inc (PK) (IMUN)

  7. Immune Therapeutics Inc (PK) (IMUN) News

IMUN

Immune Therapeutics (PK) (IMUN)

Immune Therapeutics Inc (PK)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:IMUN
DatumZeitQuelleÜberschriftSymbolFirma
15/05/202412h15Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:IMUNImmune Therapeutics Inc (PK)
01/04/202414h05Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405USOTC:IMUNImmune Therapeutics Inc (PK)
14/11/202322h22Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IMUNImmune Therapeutics Inc (PK)
14/11/202317h43Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:IMUNImmune Therapeutics Inc (PK)
02/11/202314h00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IMUNImmune Therapeutics Inc (PK)
24/10/202315h00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IMUNImmune Therapeutics Inc (PK)
14/09/202315h00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IMUNImmune Therapeutics Inc (PK)
13/09/202323h16Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IMUNImmune Therapeutics Inc (PK)
18/08/202312h02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:IMUNImmune Therapeutics Inc (PK)
14/08/202316h03Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:IMUNImmune Therapeutics Inc (PK)
20/04/202315h02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IMUNImmune Therapeutics Inc (PK)
10/04/202320h48Edgar (US Regulatory)Annual Report (10-k)USOTC:IMUNImmune Therapeutics Inc (PK)
31/03/202318h03Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:IMUNImmune Therapeutics Inc (PK)
06/03/202323h01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IMUNImmune Therapeutics Inc (PK)
12/01/202316h01Edgar (US Regulatory)Information Statements (revised) (prer14c)USOTC:IMUNImmune Therapeutics Inc (PK)
16/12/202222h33Edgar (US Regulatory)Proxy Statement - Other Information (preliminary) (pre 14c)USOTC:IMUNImmune Therapeutics Inc (PK)
15/12/202222h49Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:IMUNImmune Therapeutics Inc (PK)
15/12/202222h48Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:IMUNImmune Therapeutics Inc (PK)
14/11/202218h27Edgar (US Regulatory)Quarterly Report (10-q)USOTC:IMUNImmune Therapeutics Inc (PK)
09/11/202223h01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IMUNImmune Therapeutics Inc (PK)
12/10/202214h50Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IMUNImmune Therapeutics Inc (PK)
27/09/202220h38Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IMUNImmune Therapeutics Inc (PK)
31/08/202220h59Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:IMUNImmune Therapeutics Inc (PK)
24/08/202223h17Edgar (US Regulatory)Quarterly Report (10-q)USOTC:IMUNImmune Therapeutics Inc (PK)
02/08/202216h48Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:IMUNImmune Therapeutics Inc (PK)
22/07/202221h45Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IMUNImmune Therapeutics Inc (PK)
07/07/202223h28Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IMUNImmune Therapeutics Inc (PK)
03/06/202222h58Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IMUNImmune Therapeutics Inc (PK)
03/05/202222h22Edgar (US Regulatory)Quarterly Report (10-q)USOTC:IMUNImmune Therapeutics Inc (PK)
12/11/202116h29Edgar (US Regulatory)Quarterly Report (10-q)USOTC:IMUNImmune Therapeutics Inc (PK)
 Showing the most relevant articles for your search:USOTC:IMUN

Kürzlich von Ihnen besucht

BIT
F15454
Vontobel Financial Produ...
COIN
SPRKLEUR
COIN
XFEEUR
BIT
UB7HN7
Unicredit Bank
AMEX
FJUN
FT Vest US Equity Buffer...
USOTC
BXPHF
Botanix Pharmaceutiacls (PK)
TG
CFX
Capital One Financial
KOSDAQ
205500
Action Square
BIT
UB4Q9Q
Unicredit Bank
EU
F565T
F565T
TSX
PHYS.U
Sprott Physical Gold
NASDAQ
EQBK
Equity Bancshares
BIT
UV8B57
UniCredit Bank
ASX
QANKOS
ASX
PNI
Pinnacle Investment Mana...
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten